The availability of compounded weight loss drugs is coming to an end. A federal judge has ruled that compounding pharmacies must stop making copies of tirzepatide (the active ingredient in Mounjaro and Zepbound) since the FDA declared the shortage over. Compounded semaglutide (Ozempic, Wegovy) will also be phased out by April 22 for smaller pharmacies […]
↧